Unlocking IP Value in Pre-Revenue Tech Firms

David Durand, President of FORPIQ, IP lawyer and author: Today, we are tackling one of the most persistent challenges in the innovation ecosystem: how to assign a credible financial value to a company that has brilliant technology, protected intellectual property (IP), but no revenue yet. Joining me is valuation expert Lionel Zaba, CPA, CBV/EEE, ABV. Lionel, it is a pleasure to have you here.

To jump right in, founders of early-stage tech and life sciences startups often ask why they should bother valuing their IP before they’ve made a single dollar of sales. Why is valuing early on so critical, and why do you advocate for doing it frequently?

Lionel Zaba: Thank you, David. It’s great to be here. To answer your first question, the reality is that for a pre-revenue company, the IP is the company. Without physical assets or a trail of cash flow, a startup’s entire worth is anchored in its intangible assets—patents, trade secrets, software code, and data. If you don't value it early, you are flying blind when negotiating your initial capital.

And the consequences can be significant. Founders may end up giving away more equity than necessary, accepting unfavorable financing terms, or undervaluing their technology in strategic negotiations.

As for frequency, pre-revenue valuations are highly dynamic. A startup’s risk profile changes practically overnight. You file a provisional patent, the value goes up. A competitor launches a similar product, the value shifts. You achieve a successful clinical trial or beta test, the risk is mitigated, and the value spikes. Valuing frequently ensures that founders are capturing these inflection points and aren't leaving money on the table or misrepresenting their progress to stakeholders.

David Durand: That transitions perfectly into the primary reason most founders seek a valuation: capital raising (or attracting investment). When sitting across the table from angel investors or venture capitalists, founders face intense scrutiny. How does a formal IP valuation help a founder defend their pre-money and post-money valuations during investor Q&A?

Lionel Zaba: Investors are professionally skeptical. If a founder walks into a pitch and says, "My pre-money valuation is $5 million," the immediate investor response will be, "Prove it."

When you have a documented IP valuation, you shift the conversation from an emotional negotiation to a data-driven discussion. It shows investors that you understand the mechanics of pre- and post-money equity dilution.

Consider a startup raising $2 million. At a negotiated pre-money valuation of $4 million, the founders retain an equity stake worth $4 million on a post-financing basis. At a $6 million pre-money valuation, their retained stake is worth $6 million.

That's a $2 million difference in the implied value of their ownership from the same financing round.

When millions of dollars are at stake, the cost of a professional valuation can represent a small fraction of the economic consequences of the negotiation.

During a rigorous Q&A, founders can point to the specific technology milestones they've achieved and how the IP barriers they've established reduce market entry risks for investors. It demonstrates that the valuation isn't a number pulled out of thin air, but a metric derived from the strength of the IP portfolio, the size of the addressable market, and the current stage of development.

The question isn't simply how much a valuation costs. It's how much you could be leaving on the table without one.

David Durand: Traditionally, founders trade equity for capital. But we are increasingly seeing movement in the debt markets. Let's talk about the collateralization of IP assets for financing. How viable is IP-backed financing for pre-revenue firms? [see my submission to the Competition Bureau in the context of its Market Study: Competition in financing for Canada’s small and medium businesses].

Lionel Zaba: IP-backed financing is an increasingly interesting non-dilutive financing option, though it requires rigor. Traditional lenders look for hard assets—real estate, inventory, machinery—to secure a loan. But governments, specialized lenders, and alternative financing providers are increasingly exploring ways to recognize patents and proprietary technology as collateral.

The potential financial implications are significant. Consider a founder seeking $1 million in financing. If the company raises that amount through equity at a $4 million pre-money valuation, the new investor would receive 20% of the business.

If the company can instead secure $1 million in debt financing backed by its IP, the founders could potentially preserve that 20% ownership stake. At an illustrative future equity value of $10 million, that 20% would represent $2 million.

Of course, debt financing comes with interest, repayment obligations and risks, and not every company or IP asset will qualify.

To secure IP-backed financing, the lender needs a credible, independent assessment of the asset's economic value and its potential recoverability. You can't just say, "This patent cost us $20,000 to file." The valuation must examine what the IP could potentially fetch on the market or how it could generate future royalties through licensing or commercialization.

A professional IP valuation can therefore play an important role in unlocking financing opportunities while helping founders preserve ownership of the businesses they are building.

David Durand: Even outside of raising new capital, there is the ongoing management of existing investors. Pre-revenue phases can last years, particularly in deep tech or biotech. How does an IP valuation support value and provide shareholder reassurance, even if that value is largely hypothetical at that stage?

Lionel Zaba: "Hypothetical" doesn't mean "fictional." It means the value is contingent on future execution. Shareholders in early-stage firms know they are in for a long wait before an exit or a dividend. During that waiting period, they want to see progress.

For shareholders, the ability to demonstrate how scientific milestones, stronger IP protection or new commercial opportunities translate into economic value can be just as important as reporting financial results, particularly during the pre-revenue stage.

A frequent valuation acts as a report card. Even if the firm is burning cash, showing that the foundational IP has appreciated in value—perhaps because a patent was officially granted, or because the underlying technology was successfully adapted to a secondary market—reassures shareholders. It quantifies the team’s technical progress in financial terms, providing peace of mind that the underlying asset base is growing and that their initial investment is being protected and cultivated.

David Durand: The math behind this is famously tricky. You can’t just apply a standard multiplier to zero revenue. The selection of the valuation method is clearly important. How do you approach choosing the right methodology for a company with no historical financials?

Lionel Zaba: Selection of method is everything. If you use the wrong method, your valuation can quickly lose credibility with sophisticated investors or lenders. For pre-revenue companies, traditional valuation methods often require significant adjustments. Projecting revenues five or ten years into the future can be challenging when a product has yet to reach the market. However, that doesn't mean future cash flows cannot be considered. It means the assumptions, development milestones and associated risks become particularly important.

Several approaches may be relevant:

• The Cost Approach: We examine what it would cost to recreate or replace the intellectual property, considering development time, resources and technological complexity. This can provide a useful reference point, although development costs do not necessarily reflect economic value.

• The Market Approach: We examine comparable transactions, licensing agreements or financing rounds involving similar technologies and businesses, where reliable information is available.

• The Income Approach: We estimate the future economic benefits associated with the technology, incorporating commercialization scenarios, development milestones, probabilities of success and appropriate risk adjustments.

• Venture Capital & Angel Methods: Methods such as the Berkus Method or Scorecard Method can provide additional perspectives on early-stage company valuations, particularly when conventional financial information is limited.

The real challenge is not simply choosing a formula. It's understanding the technology, the market, the intellectual property rights and the risks that determine whether an innovation can generate economic returns.

Two companies may have similar technologies but very different values depending on their development stage, competitive position and commercialization prospects.

That's where professional judgment becomes essential. A credible valuation connects the science, the intellectual property and the commercial opportunity to an economic conclusion that founders can explain and support when making important decisions.

David Durand: A vital reminder that intellectual property is not just a legal shield; it is the fundamental economic engine of an early-stage company. Lionel, thank you for sharing your expertise with the FORPIQ community today. 

To our readers, keep on the lookout for our upcoming conference on IP-backed financing. 

Additional resources: 

Durand, D., Mulcair, C. (2023). What’s the Big Idea? The Crossroads Between Investment and IP. In: Bader, M.A., Süzeroğlu-Melchiors, S. (eds) Intellectual Property Management for Start-ups. Management for Professionals. Springer, Cham. https://doi.org/10.1007/978-3-031-16993-9_8, available at: https://link.springer.com/chapter/10.1007/978-3-031-16993-9_8

Rementilla, L. (2023). Intellectual Property-Backed Financing. In: Bader, M.A., Süzeroğlu-Melchiors, S. (eds) Intellectual Property Management for Start-ups. Management for Professionals. Springer, Cham. https://doi.org/10.1007/978-3-031-16993-9_9

Tarek Miloud, Arild Aspelund, Mathieu Cabrol. Startup valuation by venture capitalists: an empirical study. Venture Capital, 2012, 14 (2-3), pp.151-174. ⟨10.1080/13691066.2012.667907⟩. ⟨hal-00951664⟩, available at: https://hal.science/hal-00951664/document 

Björn Imbierowicz, Christian Rauch, What drives startup valuations?, Journal of Banking & Finance, Volume 168, 2024, 107251, ISSN 0378-4266, https://doi.org/10.1016/j.jbankfin.2024.107251, available at: https://www.sciencedirect.com/science/article/pii/S0378426624001651 

Ewing Marion Kauffman Foundation, Valuing Pre-revenue Companies, available at: https://www.angelcapitalassociation.org/data/Documents/Resources/AngelCapitalEducation/ACEF_-_Valuing_Pre-revenue_Companies.pdf

IP Valuation of the Early Stage Technology National Workshop “Innovation Promotion and Technology Transfer” Belgrade, June 21 and 22, 2011, WIPO, available at: https://www.wipo.int/export/sites/www/dcea/en/meetings/2011/tt_belgrade/docs/Topic_13_IP_Valuation_of_Early_Stage_Technology_Spasic.pdf

Chahreddine Abbes, Amélie Lafrance-Cooke, Nicholas Johnston, Intellectual property in the context of firms’ exit strategies: The role of patents, Statistics Canada, Catalogue no. 36-28-0001, Economic and Social Reports Vol. 5, no.6, June 2025, available at: https://www150.statcan.gc.ca/n1/en/pub/36-28-0001/2025006/article/00005-eng.pdf?st=kuASwGvo

Ronald J. Mann and Thomas W. Sager, Patents, Venture Capital, and Software Start-ups, available at: https://www.columbia.edu/~mr2651/Data/SagerPaper.pdf 

Amanda Hellström, Sara Nilsson, Mikael Andersson, Ulf Håkanson, Intellectual property for generating value for start-up companies in key enabling technologies, Biotechnology Research and Innovation, Volume 3, Issue 1, 2019, Pages 80-90, ISSN 2452-0721, https://doi.org/10.1016/j.biori.2019.01.001, available at: https://www.sciencedirect.com/science/article/pii/S2452072119300036

Sati-Salmah Sukarmijan, Olivia De Vega Sapong, The Importance of Intellectual Property for SMEs; Challenges and Moving Forward, UMK Procedia, Volume 1, 2014, Pages 74-81,

ISSN 2214-0115, https://doi.org/10.1016/j.umkpro.2014.07.010, available at: https://www.sciencedirect.com/science/article/pii/S2214011514000113

Shigeki Kamiyama, Jerry Sheehan, Catalina Martinez, OECD Science, Technology and Industry Working Papers 2006/05, Valuation and Exploitation of Intellectual Property, https://dx.doi.org/10.1787/307034817055, available at: https://www.oecd.org/content/dam/oecd/en/publications/reports/2006/06/valuation-and-exploitation-of-intellectual-property_g17a1932/307034817055.pdf

Aysun Beyazkilic Koc, Nihan Yildirim, A multi-criteria decision framework for IP valuation method selection: “Valuation case” matters, World Patent Information, Volume 73, 2023, 102176, ISSN 0172-2190, https://doi.org/10.1016/j.wpi.2023.102176, available at: https://www.sciencedirect.com/science/article/pii/S0172219023000066